LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.07M 66K 66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
79K 97K 66K 175K 965K 3.04M 5.26M 7.34M 8.71M 8.67M 8.35M 6.12M 4.51M 2.55M 746K 867K 311K 212K
Gross Profit
4.99M -31K n/a -175K -965K -3.04M -5.26M -7.34M -8.71M -8.67M -8.35M -6.12M -4.51M -2.55M -746K -867K -311K -212K
Operating Income
-61.96M -59.45M -58.61M -57.99M -58.72M -65.33M -73.11M -85.26M -97.73M -103.55M -105.64M -97.83M -86.28M -77.03M -60.44M -49.83M -38.99M -22.75M
Interest Income
9.87M 10.09M 8.55M 8.55M 8.77M 6.56M 8.36M 7.95M 6.46M 6.21M 3.62M 1.47M n/a n/a n/a n/a n/a n/a
Pretax Income
-51.9M -47.74M -49.77M -60.03M -72.31M -117.36M -124.65M -126.33M -128.53M -99.88M -102.08M -96.42M -86.33M -77.19M -70.76M -115.37M -104.16M -87.94M
Net Income
-52.4M -47.74M -49.77M -60.03M -72.31M -117.36M -124.65M -126.33M -128.53M -99.88M -102.08M -96.42M -86.33M -77.19M -70.76M -115.37M -104.16M -87.94M
Selling & General & Admin
39.75M 34.34M 28.78M 33.88M 37.89M 35.86M 35.71M 29.54M 26.9M 28.48M 28.9M 28.34M 25.85M 23.68M 21.77M 15.84M 11.93M 8.04M
Research & Development
27.2M 25.08M 29.8M 23.93M 19.87M 26.43M 32.14M 48.38M 62.13M 66.39M 68.4M 63.36M 55.91M 50.8M 37.93M 33.12M 26.74M 14.5M
Other Expenses
-25K -25K -25K n/a n/a -18K -72K -71K -71K -53K 1K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
66.92M 59.4M 58.56M 57.82M 57.76M 62.29M 67.85M 77.92M 89.03M 94.87M 97.29M 91.7M 81.76M 74.48M 59.7M 48.96M 38.68M 22.54M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 20K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
66.96M 59.45M 58.61M 57.99M 58.72M 65.33M 73.11M 85.26M 97.73M 103.55M 105.64M 97.83M 86.28M 77.03M 60.44M 49.83M 38.99M 22.75M
Income Tax Expense
501K 1K 1K -179K -179K -179K 2M 2.48M 2.48M 2.48M 303K -71.39K -71.39K -71.39K -71.39K n/a n/a n/a
Shares Outstanding (Basic)
28.08M 27.53M 27.49M 27.17M 25.61M 4.72M 8.29M 8.18M 8.11M 7.98M 7.96M 7.89M 7.8M 7.72M 8.29M 8.3M 8M 8.3M
Shares Outstanding (Diluted)
28.08M 27.53M 27.49M 27.17M 25.61M 4.72M 8.29M 8.18M 8.11M 7.98M 7.96M 7.89M 7.8M 7.72M 8.29M 8.3M 8M 8.3M
EPS (Basic)
-1.9 -1.77 -4.77 -7.08 -9.45 -15.87 -15.34 -15.66 -16.04 -12.64 -13.03 -12.22 -10.85 -9.62 -8.61 -13.99 -12.64 -10.61
EPS (Diluted)
-1.9 -1.77 -4.77 -7.08 -9.45 -15.87 -15.34 -15.66 -16.04 -12.64 -13.03 -12.22 -10.85 -9.62 -8.61 -13.99 -12.64 -10.61
EBITDA
-61.87M -59.36M -58.55M -66.13M -74.88M -75.5M -81.06M -82.82M -83.64M -93.29M -95.89M -90.3M -81.82M -74.66M -70.02M -114.5M -103.85M -87.71M
EBIT
-56.65M -50.05M -49.21M -59.48M -69.13M -73.83M -70.36M -56.57M -61.38M -73.08M -86.61M -96.42M -86.33M -77.19M -70.76M -115.37M -104.16M -87.92M
Depreciation & Amortization
90K 89K 58K 175K 965K 3.04M 5.26M 7.34M 8.71M 8.67M 8.35M 6.2M 4.58M 2.62M 817.39K 867K 691K 592K